位置:首页 > 蛋白库 > GATD_STAAN
GATD_STAAN
ID   GATD_STAAN              Reviewed;         243 AA.
AC   A0A0H3JN63;
DT   08-MAY-2019, integrated into UniProtKB/Swiss-Prot.
DT   16-SEP-2015, sequence version 1.
DT   03-AUG-2022, entry version 34.
DE   RecName: Full=Lipid II isoglutaminyl synthase (glutamine-hydrolyzing) subunit GatD {ECO:0000255|HAMAP-Rule:MF_02213, ECO:0000305};
DE            EC=6.3.5.13 {ECO:0000255|HAMAP-Rule:MF_02213, ECO:0000269|PubMed:22291598, ECO:0000269|PubMed:30154570};
DE   AltName: Full=Lipid II isoglutaminyl synthase glutaminase subunit {ECO:0000255|HAMAP-Rule:MF_02213, ECO:0000305};
DE            EC=3.5.1.2 {ECO:0000255|HAMAP-Rule:MF_02213, ECO:0000269|PubMed:22291598};
GN   Name=gatD {ECO:0000255|HAMAP-Rule:MF_02213, ECO:0000303|PubMed:22291598};
GN   OrderedLocusNames=SA1707 {ECO:0000312|EMBL:BAB42977.1};
OS   Staphylococcus aureus (strain N315).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;
OC   Staphylococcus.
OX   NCBI_TaxID=158879;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=N315;
RX   PubMed=11418146; DOI=10.1016/s0140-6736(00)04403-2;
RA   Kuroda M., Ohta T., Uchiyama I., Baba T., Yuzawa H., Kobayashi I., Cui L.,
RA   Oguchi A., Aoki K., Nagai Y., Lian J.-Q., Ito T., Kanamori M.,
RA   Matsumaru H., Maruyama A., Murakami H., Hosoyama A., Mizutani-Ui Y.,
RA   Takahashi N.K., Sawano T., Inoue R., Kaito C., Sekimizu K., Hirakawa H.,
RA   Kuhara S., Goto S., Yabuzaki J., Kanehisa M., Yamashita A., Oshima K.,
RA   Furuya K., Yoshino C., Shiba T., Hattori M., Ogasawara N., Hayashi H.,
RA   Hiramatsu K.;
RT   "Whole genome sequencing of meticillin-resistant Staphylococcus aureus.";
RL   Lancet 357:1225-1240(2001).
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, PATHWAY,
RP   SUBUNIT, DISRUPTION PHENOTYPE, ACTIVE SITE, AND MUTAGENESIS OF CYS-94.
RC   STRAIN=N315;
RX   PubMed=22291598; DOI=10.1371/journal.ppat.1002509;
RA   Muench D., Roemer T., Lee S.H., Engeser M., Sahl H.G., Schneider T.;
RT   "Identification and in vitro analysis of the GatD/MurT enzyme-complex
RT   catalyzing lipid II amidation in Staphylococcus aureus.";
RL   PLoS Pathog. 8:E1002509-E1002509(2012).
RN   [3] {ECO:0007744|PDB:6GS2, ECO:0007744|PDB:6H5E}
RP   X-RAY CRYSTALLOGRAPHY (2.04 ANGSTROMS) IN COMPLEXES WITH MURT, FUNCTION,
RP   CATALYTIC ACTIVITY, SUBUNIT, DOMAIN, ACTIVE SITE, AND MUTAGENESIS OF
RP   CYS-94.
RX   PubMed=30154570; DOI=10.1038/s41598-018-31098-x;
RA   Noldeke E.R., Muckenfuss L.M., Niemann V., Muller A., Stork E., Zocher G.,
RA   Schneider T., Stehle T.;
RT   "Structural basis of cell wall peptidoglycan amidation by the GatD/MurT
RT   complex of Staphylococcus aureus.";
RL   Sci. Rep. 8:12953-12953(2018).
CC   -!- FUNCTION: The lipid II isoglutaminyl synthase complex catalyzes the
CC       formation of alpha-D-isoglutamine in the cell wall lipid II stem
CC       peptide (PubMed:22291598, PubMed:30154570). The GatD subunit catalyzes
CC       the hydrolysis of glutamine to glutamate and ammonia. The resulting
CC       ammonia molecule is channeled to the active site of MurT
CC       (PubMed:22291598). {ECO:0000269|PubMed:22291598,
CC       ECO:0000269|PubMed:30154570}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-gamma-D-Glu-L-Lys-
CC         D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl diphosphate + H2O + L-
CC         glutamine = ADP + beta-D-GlcNAc-(1->4)-Mur2Ac(oyl-L-Ala-D-
CC         isoglutaminyl-L-Lys-D-Ala-D-Ala)-di-trans,octa-cis-undecaprenyl
CC         diphosphate + H(+) + L-glutamate + phosphate; Xref=Rhea:RHEA:57928,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:29985,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:58359,
CC         ChEBI:CHEBI:60033, ChEBI:CHEBI:62233, ChEBI:CHEBI:456216;
CC         EC=6.3.5.13; Evidence={ECO:0000255|HAMAP-Rule:MF_02213,
CC         ECO:0000269|PubMed:22291598, ECO:0000269|PubMed:30154570};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-glutamine = L-glutamate + NH4(+);
CC         Xref=Rhea:RHEA:15889, ChEBI:CHEBI:15377, ChEBI:CHEBI:28938,
CC         ChEBI:CHEBI:29985, ChEBI:CHEBI:58359; EC=3.5.1.2;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_02213,
CC         ECO:0000269|PubMed:22291598};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 7.5-7.8 for isoglutaminyl synthase activity.
CC         {ECO:0000269|PubMed:22291598};
CC   -!- PATHWAY: Cell wall biogenesis; peptidoglycan biosynthesis.
CC       {ECO:0000255|HAMAP-Rule:MF_02213, ECO:0000269|PubMed:22291598}.
CC   -!- SUBUNIT: Forms a heterodimer with MurT. {ECO:0000255|HAMAP-
CC       Rule:MF_02213, ECO:0000269|PubMed:22291598,
CC       ECO:0000269|PubMed:30154570}.
CC   -!- DOMAIN: The GatD/MurT complex has an open, boomerang-shaped
CC       conformation in which GatD is docked onto one end of MurT. Both
CC       proteins contribute to the catalytic triad.
CC       {ECO:0000269|PubMed:30154570}.
CC   -!- DISRUPTION PHENOTYPE: The gatD-murT double mutant displays
CC       susceptibility to diverse carbapenem and cephalosporin beta-lactam
CC       antibiotics and shows increased susceptibility to plectasin.
CC       {ECO:0000269|PubMed:22291598}.
CC   -!- SIMILARITY: Belongs to the CobB/CobQ family. GatD subfamily.
CC       {ECO:0000255|HAMAP-Rule:MF_02213, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BA000018; BAB42977.1; -; Genomic_DNA.
DR   RefSeq; WP_000544969.1; NC_002745.2.
DR   PDB; 6GS2; X-ray; 2.04 A; A/C=1-243.
DR   PDB; 6H5E; X-ray; 2.14 A; A/C=1-243.
DR   PDBsum; 6GS2; -.
DR   PDBsum; 6H5E; -.
DR   AlphaFoldDB; A0A0H3JN63; -.
DR   SMR; A0A0H3JN63; -.
DR   EnsemblBacteria; BAB42977; BAB42977; BAB42977.
DR   KEGG; sau:SA1707; -.
DR   HOGENOM; CLU_064047_0_0_9; -.
DR   OMA; GTYMHGP; -.
DR   BRENDA; 6.3.5.13; 3352.
DR   UniPathway; UPA00219; -.
DR   Proteomes; UP000000751; Chromosome.
DR   GO; GO:0140282; F:carbon-nitrogen ligase activity on lipid II; IDA:CACAO.
DR   GO; GO:0004359; F:glutaminase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0009236; P:cobalamin biosynthetic process; IEA:InterPro.
DR   GO; GO:0006541; P:glutamine metabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0009252; P:peptidoglycan biosynthetic process; IEA:UniProtKB-UniRule.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   CDD; cd01750; GATase1_CobQ; 1.
DR   Gene3D; 3.40.50.880; -; 1.
DR   HAMAP; MF_02213; Lipid_II_synth_GatD; 1.
DR   InterPro; IPR029062; Class_I_gatase-like.
DR   InterPro; IPR033949; CobQ_GATase1.
DR   InterPro; IPR011698; GATase_3.
DR   InterPro; IPR043702; Lipid_II_synth_GatD.
DR   Pfam; PF07685; GATase_3; 1.
DR   SUPFAM; SSF52317; SSF52317; 1.
DR   PROSITE; PS51274; GATASE_COBBQ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell shape; Cell wall biogenesis/degradation;
KW   Glutamine amidotransferase; Hydrolase; Ligase; Peptidoglycan synthesis.
FT   CHAIN           1..243
FT                   /note="Lipid II isoglutaminyl synthase (glutamine-
FT                   hydrolyzing) subunit GatD"
FT                   /id="PRO_0000446941"
FT   DOMAIN          6..197
FT                   /note="GATase cobBQ-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00606"
FT   ACT_SITE        94
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02213,
FT                   ECO:0000255|PROSITE-ProRule:PRU00606,
FT                   ECO:0000305|PubMed:22291598, ECO:0000305|PubMed:30154570"
FT   ACT_SITE        189
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_02213,
FT                   ECO:0000255|PROSITE-ProRule:PRU00606"
FT   BINDING         128
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:A0A0H2WZ38,
FT                   ECO:0000255|HAMAP-Rule:MF_02213"
FT   MUTAGEN         94
FT                   /note="C->G,S: Cannot use glutamine. Abolishes amidation of
FT                   lipid II."
FT                   /evidence="ECO:0000269|PubMed:22291598,
FT                   ECO:0000269|PubMed:30154570"
FT   STRAND          3..9
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   TURN            10..13
FT                   /evidence="ECO:0007829|PDB:6H5E"
FT   HELIX           17..31
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   TURN            32..34
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          36..43
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          54..58
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   HELIX           63..73
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   HELIX           74..76
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   HELIX           77..85
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          90..93
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   HELIX           95..98
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          101..105
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          111..113
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          117..119
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          121..136
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          138..140
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          142..154
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          160..166
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          169..173
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          175..180
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   STRAND          183..186
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   TURN            193..195
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   HELIX           197..211
FT                   /evidence="ECO:0007829|PDB:6GS2"
FT   HELIX           223..243
FT                   /evidence="ECO:0007829|PDB:6GS2"
SQ   SEQUENCE   243 AA;  27430 MW;  897C70CD1456A32B CRC64;
     MHELTIYHFM SDKLNLYSDI GNIIALRQRA KKRNIKVNVV EINETEGITF DECDIFFIGG
     GSDREQALAT KELSKIKTPL KEAIEDGMPG LTICGGYQFL GKKYITPDGT ELEGLGILDF
     YTESKTNRLT GDIVIESDTF GTIVGFENHG GRTYHDFGTL GHVTFGYGNN DEDKKEGIHY
     KNLLGTYLHG PILPKNYEIT DYLLEKACER KGIPFEPKEI DNEAEIQAKQ VLIDRANRQK
     KSR
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024